Catalyst Wire Dossier Catalyst Wire Dossier

NEURONTIN

gabapentin · Parke-Davis Div of Pfizer Inc
Drug timelines are a Plus or Pro feature.

65 regulatory and trial events tracked for NEURONTIN, covering 2006-05-03 to 2025-12-10. Get the full timeline:

Most recent: Clinical Trial Update: Oral Gabapentin and Median Nerve Mobilization in the Treatment of Carpal Tunnel Syndrome [Phase 4]

See pricing